Three bills in the Vermont legislature name the 340B program. Two became law. Here is what each one is, how far it has got and where to read it.
2025-2026 Regular Session
Ended 29 May 2026
About 340B
Contract pharmacy access
Reporting
H 266An act relating to the 340B prescription drug pricing program
Bars drug makers from restricting delivery of 340B drugs to contract pharmacies, from requiring claims data as a condition, and from giving 340B pricing as a rebate instead of a discount at purchase. Requires hospitals in 340B to report yearly figures, which a state board posts online.
Became law11 June 2025
Latest step
13 June 2025: House message: Governor approved bill on June 11, 2025
Sponsor
Alyssa Black
Introduced
19 February 2025
Where it names 340B: H 266
No. 55 Page 1 of 8 2025 No. 55. An act relating to the 340B prescription drug pricing program. (H.266) It is hereby enacted by the General Assembly of the State of Vermont: Sec. 1. 18 V.S.A. chapter 91, subchapter 6 is added to …
H 611An act relating to miscellaneous provisions affecting the Department of Vermont Health Access
In a wider law on the state's health access department, bars drug makers from requiring a covered entity's claims or other data as a condition of delivering 340B drugs to the entity or its contract pharmacy, and repeals the rule that 340B pricing be a discount at purchase, not a rebate.
Became law29 May 2026
Latest step
29 May 2026: House message: Governor approved bill on June 8, 2026
Sponsor
Daisy Berbeco
Introduced
8 January 2026
Where it names 340B: H 611
… Access, to one or more health insurers, or both during the specified period of time; *** Sec. 2. 18 V.S.A. § 4682 is amended to read: § 4682. DISCRIMINATION AGAINST 340B ENTITIES PROHIBITED *** (b) A manufacturer or its agent shall not directly or indirectly require a 340B covered entity to submit any claims, utilization, encounter, …
H 202An act relating to increasing the transparency of prescription drug costs and spending
In a wider drug cost transparency bill, would require hospitals to report each year to a state board on their 340B costs, payments, vendors and use of savings, and would require all covered entities to tell patients each year if their drugs were bought through 340B.
Introduced12 February 2025Session ended 29 May 2026
Latest step
12 February 2025: Read first time and referred to the Committee on Health Care
Sponsor
Mari Cordes
Where it names 340B: H 202
… Representative Cordes of Bristol Referred to Committee on Date: Subject: Health; health insurance; prescription drugs; pharmacy benefit managers; pharmacies; hospitals; 340B drug pricing program Statement of purpose of bill as introduced: This bill proposes to prohibit a pharmacy benefit manager from requiring a person covered by a health …